Remarkable clinical responses of non-fluctuating Parkinson's disease (PD) after alternating catechol O-methyltransferase inhibitors: case series switching from entacapone 200 ∼ 300 mg/day to opicapone 25 mg/day

NEUROLOGICAL SCIENCES

SPRINGER-VERLAG ITALIA SRL

1. JSPS KAKENHI [JP 20K07777]